Close Menu
May 02, 2019
Sponsored by
Qiagen: Nov 16, 2014

Syndromic Testing in a Small Urban Hospital: Impact on the Lab, Patient Outcomes, and Medical Decision Making

GenomeWebinar

Clinical Microbiologist,
Ikazia Hospital

This webinar discusses the implementation of a rapid 24/7 PCR service in a small urban hospital setting.

Modern PCR technologies are changing the workflow of medical microbiology laboratories, making it possible to get molecular test results within an hour instead of days to weeks. Smaller and cheaper analyzers also make multiplex PCR techniques possible for smaller laboratories without a molecular department.

This webinar illustrates the impact of new PCR technologies in the hospital setting. Our speaker, Michiel van Rijn, is a clinical microbiologist and head of the Department of Clinical Microbiology at the Ikazia Hospital in Rotterdam. Although the Ikazia hospital is one of the smaller hospitals in Rotterdam (360 beds), it has offered a "24/7" PCR service to its medical staff for 10 years, starting with molecular screening for methicillin-resistant Staphylococcus aureus in 2009. The hospital has expanded its portfolio in the last decade, and most recently rolled out multiplex syndromic testing in 2018.

In this webinar, Dr. van Rijn speaks about the implementation of a rapid 24/7 PCR service in his hospital and the effects of this service on patient outcomes and clinical decision making strategies. In particular, he shares his experiences with QIAstat-Dx syndromic testing and his expectation of further use of this technique in the future.

QIAstat-Dx is coming soon. Currently available as DiagCORE. DiagCORE is not available in all countries.

Sponsored by

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.